<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55637</article-id><article-id pub-id-type="doi">10.7554/eLife.55637</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-153716"><name><surname>Uehara</surname><given-names>Hironori</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6133-4918</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2809"><name><surname>Zhang</surname><given-names>Xiaohui</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179430"><name><surname>Pereira</surname><given-names>Felipe</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179431"><name><surname>Narendran</surname><given-names>Siddharth</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179432"><name><surname>Choi</surname><given-names>Susie</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179433"><name><surname>Bhuvanagiri</surname><given-names>Sai</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179434"><name><surname>Liu</surname><given-names>Jinlu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179435"><name><surname>Ravi Kumar</surname><given-names>Sangeetha</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179436"><name><surname>Bohner</surname><given-names>Austin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179437"><name><surname>Carroll</surname><given-names>Lara</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2813"><name><surname>Archer</surname><given-names>Bonnie</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179438"><name><surname>Zhang</surname><given-names>Yue</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179439"><name><surname>Liu</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2824"><name><surname>Gao</surname><given-names>Guangping</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179440"><name><surname>Ambati</surname><given-names>Jayakrishna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40130"><name><surname>Jun</surname><given-names>Albert S</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2593"><name><surname>Ambati</surname><given-names>Balamurali K</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Phil and Penny Knight Campus for Accelerating Scientific Impact</institution>, <institution>University of Oregon</institution>, <addr-line><named-content content-type="city">Eugene</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Moran Eye Center</institution>, <institution>University of Utah</institution>, <addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Ophthalmology</institution>, <institution>University of Virginia</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Ophthalmology and Visual Sciences</institution>, <institution>University of Utah</institution>, <addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Ophthalmology</institution>, <institution>Loma Linda University</institution>, <addr-line><named-content content-type="city">Loma Linda</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Moran eye center</institution>, <institution>University of Utah</institution>, <addr-line><named-content content-type="city">Salt lake city</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Division of Epidemiology, Department of Internal Medicine</institution>, <institution>University of Utah</institution>, <addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Horae Gene Therapy Center</institution>, <institution>University of Massachusetts</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Ophthalmology</institution>, <institution>Wilmer Eye Institute, Johns Hopkins School of Medicine</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Ophthalmology</institution>, <institution>Moran Eye Center, University of Utah</institution>, <addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-2493"><name><surname>Cepko</surname><given-names>Constance L</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>uhironori0916@gmail.com</email> (HU);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>bambati@gmail.com</email> (BA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>06</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e55637</elocation-id><history><date date-type="received"><day>31</day><month>01</month><year>2020</year></date><date date-type="accepted"><day>07</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Uehara et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Uehara et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55637-v1.pdf"/><abstract><p>A missense mutation of collagen type VIII alpha 2 chain (<italic>COL8A2</italic>) gene leads to early onset Fuchs' endothelial corneal dystrophy (FECD), which progressively impairs vision through loss of corneal endothelial cells. We demonstrate that CRISPR/Cas9-based postnatal gene editing achieves structural and functional rescue in a mouse model of FECD. A single intraocular injection of an adenovirus encoding both the Cas9 gene and guide RNA (Ad-Cas9-Col8a2gRNA), efficiently knocked down mutant <italic>COL8A2</italic> expression in corneal endothelial cells, prevented endothelial cell loss, and rescued corneal endothelium pumping function in adult <italic>Col8a2</italic> mutant mice. There were no adverse sequelae on histology or electroretinography. <italic>Col8a2</italic> start codon disruption represents a non-surgical strategy to prevent vision loss in early-onset FECD. As this demonstrates the ability of Ad-Cas9-gRNA to restore phenotype in adult post-mitotic cells, this method may be widely applicable to adult-onset diseases, even in tissues affected with disorders of non-reproducing cells.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000053</institution-id><institution>National Eye Institute</institution></institution-wrap></funding-source><award-id>R01EY017950</award-id><principal-award-recipient><name><surname>Ambati</surname><given-names>Balamurali K</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001818</institution-id><institution>Research to Prevent Blindness</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ambati</surname><given-names>Balamurali K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#15-11024 and #18-10016) of the University of Utah.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>High-throughput Sequencing data have been deposited in GEO under accession codes GSE146999.  Source data files have been provided as excel files.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Hironori Uehara</collab></person-group><year iso-8601-date="2020">2020</year><source>Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146999">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146999</ext-link><comment>NCBI Gene Expression Omnibus, GSE146999</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-55637-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>